Clinical Trial

A Study of Propranolol to Treat Kaposi Sarcoma

Name: A Study of Propranolol to Treat Kaposi Sarcoma — clinical trial record (NCT05797662)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A clinical study of propranolol for the treatment of Kaposi Sarcoma in children and adults. This study will be an open-label single armed treatment trial that will test the effectiveness and the safety of treating Kaposi Sarcoma with propranolol.

Protocol Amendment History 1 change

notable Trial sites reduced: 9 -> 6 locations 2026-08-12

Trial Details

NCT Number	NCT05797662
Lead Sponsor	AIDS Malignancy Consortium Collaborators: National Cancer Institute (NCI)
Conditions	Kaposi Sarcoma
Enrollment	25 participants
Start Date	2026-09
Primary Completion	2029-04 (estimated)
Study Completion	2029-04 (estimated)
Updated on ClinicalTrials.gov	2026-08-11